FUJIFILM Diosynth Biotechnologies provides contract development and manufacturing services for biologics, vaccines, and advanced therapies.

FUJIFILM Diosynth Biotechnologies

IPhone / Mobile Compatible

Viewport Meta

Euro

Google Tag Manager

Apple Mobile Web Clips Icon

Google Font API

Content Delivery Network

WordPress

reCAPTCHA

Yoast WordPress SEO Plugin

Chief Operating Officer, College Station, Texas Site

Gerry Farrell

Chief Information Officer and Senior Vice President

Ravi Narasimhan

Global Business Process Owner, PD ELN System

Sean Stowe

President at Mariana Butte Consulting

Ted Landvogt

Vice President, Global Program Management, Advanced Therapies

Gregory Scott

Vice President Quality Operations

Mark Kuenzi

VP Engineering and Asset Development

Thomas Page

Senior Director Quality Assurance

Abel Hastings

Associate Director, Analytical Development

Adam Connor

Operations

Aj Troiano

Sharyn Farnsworth

Associate Principal Scientist

Lars Petersen

President & Chief Executive Officer

Principal Scientist

Morten Munk

Director - Global Alliance Management

United States Biotechnology Companies (Top 10K)

East Coast Health Care Companies (Top 10K)

Health Care Companies With More Than $100M in Revenue

Companies With More Than $100M in Revenue (Top 10K)

Fujifilm Diosynth Biotechnologies is a leader in contract process development with a proven record in clinical & commercial cGMP contract manufacturing of complex recombinant proteins, vaccines, antibody derivatives, enzymes and fusion proteins.

Morrisville

North Carolina

United States

North America

Fujifilm Diosynth Biotechnologies

Pharmaceutical CDMO Market Size Projected to Reach USD 368.70 Bn by 2034

FUJIFILM Diosynth Biotechnologies Celebrates the Expansion Completion at its California Cell Therapy Facility

Teesside pharma firm Fujifilm Diosynth Biotechnologies opens new £100m facility in Billingham

“Talent, Talent, Talent” Drives Fujifilm Diosynth’s $3.2B NC Expansion

Fujifilm plots another $1.2B expansion, hiring spree at North Carolina site

Fujifilm Diosynth to layoff dozens at RTP site in North Carolina

Fujifilm unit to announce $1B NC expansion ahead of Japanese prime minister's visit

Fujifilm Diosynth adds 680 jobs, $1 billion to North Carolina expansion

FUJIFILM Diosynth Biotechnologies Expanding Manufacturing Operations in Holly Springs

Provides cGMP manufacturing of biologics using mammalian and insect cell cultures for recombinant proteins and monoclonal antibodies.

Offers cell line development using a CHO DG44-derived cell line for monoclonal antibodies and CHO-expressed molecules.

Evaluates antibody candidates for manufacturability, including stability and expression levels, before cell line development.

Develops and optimizes processes for fed batch and continuous cultures, including process development for a range of expression systems.

Specializes in the development and cGMP manufacturing of recombinant proteins using microbial hosts like E.coli, P.pastoris, and S.cerevisiae.

Offers continuous biomanufacturing services with end-to-end automation and integration of upstream and downstream processes.

Denmark

Europe

United Kingdom

India

Asia

Austria

HTML5

Adobe Fonts

Wordpress

Comodo PositiveSSL Certificates

Apache Server

GlobalSign

Gravity Forms

Fonts.com

Modernizr

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Sep 29, 2024 4:30 PM	816fbeb3
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Sep 29, 2024 4:30 PM	beb42bf9
crunchbase trigger	general	Dec 4, 2024 8:54 AM	285474f6
crunchbase profile	general	Dec 4, 2024 2:27 PM	c0be1858
li profile	general
translate crunchbase fundingrounds	general	Dec 4, 2024 3:03 PM	13e52d90
peers	general	Sep 29, 2024 4:30 PM	29f91ca4
news basic	general	Sep 29, 2024 4:30 PM	c8dc24ef
bundesanzeiger	filings
financials download nd	financials
private financials	financials

COM:FUJIFILMDIOSYNTH

FUJIFILM Diosynth Biotechnologies